CRYO CELL INTERNATIONAL INC Cash Flow Statement
CCEL|7 years of annual SEC 10-K data (FY2011-FY2017)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 7 fiscal years. All figures from audited SEC 10-K filings.
CRYO CELL INTERNATIONAL INC generated $5M in operating cash flow and $5M in free cash flow in FY2017. Free cash flow margin was 20.1% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Net Income | -$1.3M | $8.1M | $553.6K | $27.4K | -$6.3M | -$2.1M | $3.5M |
| Depreciation & Amortization | $154.7K | $92.1K | $171.3K | $188.1K | $204.1K | $361.2K | $294.1K |
| Operating Cash Flow | $5.0M | $4.9M | $1.6M | $822.0K | $360.9K | $819.1K | $2.3M |
| Capital Expenditures | $343.0K | $108.5K | $120.5K | $349.8K | $133.5K | $505.7K | $398.9K |
| Free Cash Flow | $4.6M | $4.7M | $1.4M | $472.2K | $227.4K | $313.4K | $1.9M |
| Share Buybacks | $10.8M | $3.2M | $2.7M | $738.6K | $1.7M | $1.7M | - |
| FCF Margin | 20.1% | 22.5% | 7.1% | 2.5% | 1.3% | 1.8% | 10.9% |